-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
days ago, CCTV broadcast the topic, announced the latest progress of medical insurance said: the national medical insurance drug catalog adjustment work is under intense, the future will have more life-saving drugs into the medical insurance reimbursement directory, to ensure that people can afford to see the disease.
Previously released "2019 National Health Insurance Drug Catalog Adjustment Work Programme" shows that the regular catalog is to be released in July, to be negotiated in August-September, to be released in September-October negotiations access directory. That means a new health-care catalog is expected by the end of the month.
According to the plan, the adjustment of the medical insurance catalogue will give priority to the treatment of major diseases such as basic drugs, cancer and rare diseases, chronic diseases, children's medicine, emergency rescue drugs, etc., and give priority to the selection of varieties with sufficient evidence to prove that they are clinically necessary, safe, effective and reasonably priced, and the progress disclosed in this topic is also in line with the general direction of the program.
In addition, the special report also said that the high price of imported anti-cancer drugs, people can not afford, has become a problem that plagues many cancer patients to treat. In recent years, the state through the anti-cancer drug health insurance access negotiations, has more than 30 kinds of anti-cancer drugs into the list of health insurance, the highest decline of 71%. (Guangzhou Daily
)